Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. (2017)

First Author: Read ML
Attributed to:  RE-ENGINEERING RADIOIODINE THERAPY FOR THE 21ST CENTURY funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2017.154

PubMed Identifier: 28504713

Publication URI: http://europepmc.org/abstract/MED/28504713

Type: Journal Article/Review

Volume: 36

Parent Publication: Oncogene

Issue: 37

ISSN: 0950-9232